VWR to Distribute DuPont Dx's PCR-based Platform in the US for Food Safety Testing | GenomeWeb

NEW YORK (GenomeWeb) – DuPont Diagnostics today announced an exclusive distribution agreement granting VWR rights in the US to sell the DuPont BAX System Q7 instrument, assays, and related products. 

The BAX platform is a PCR-based pathogen detection technology for the food industry. It provides automated testing for foodborne pathogens, spoilage organisms, and other microbes in raw ingredients, finished products, and manufacturing environments, DuPont Diagnostics, part of DuPont Nutrition & Health, said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.